History of allergic reactions attributed to compounds of similar chemical or biologic composition to olaparib, cediranib or bevacizumab
Patients with a history of allergic reactions attributed to compounds of similar chemical or biologic composition to LY or to its formulation are not eligible
History of allergic reactions attributed to compounds of similar chemical or biologic composition to olaparib and ramucirumab
History of allergic reactions attributed to compounds of similar chemical or biologic composition to study drugs (e.g. cisplatin)
History of allergic reactions attributed to compounds of similar chemical or biologic composition to MLN (TAK-)
Patients must not have a history of allergic reactions attributed to compounds of similar chemical or biologic composition to nivolumab
History of allergic reactions attributed to compounds of chemical or biologic composition similar to palbociclib.
History of allergic reactions attributed to compounds of similar chemical or biologic composition to brentuximab vedotin
History of allergic reactions attributed to compounds of similar chemical or biologic composition to hetIL-.
Patients with a history of allergic reactions attributed to compounds of similar chemical or biologic composition to ibrutinib are not eligible
History of allergic reactions attributed to compounds of similar chemical or biologic composition to phenelzine or other monoamine oxidase inhibitors
History of allergic reactions attributed to compounds of similar chemical or biologic composition to ruxolitinib or trastuzumab
History of allergic reactions attributed to compounds of similar chemical or biologic composition to afatinib or docetaxel
History of allergic reactions attributed to compounds of similar chemical or biologic composition to GM-CSF
History of allergic reactions attributed to compounds of similar chemical or biologic composition to sotatercept, lenalidomide, pomalidomide, or dexamethasone
History of allergic reactions attributed to compounds of similar chemical or biologic composition to eribulin
History of allergic reactions attributed to compounds of similar chemical or biologic composition to pembrolizumab and trebananib including history of allergic reactions to bacterially produced proteins
Patients with a history of allergic reactions attributed to compounds of similar chemical or biologic composition to PT are ineligible
History of allergic reactions attributed to compounds of similar chemical or biologic composition to bavituximab
Patients may not have a history of allergic reactions attributed to compounds of similar chemical or biologic composition to metformin
History of allergic reactions attributed to compounds of similar chemical or biologic composition to palbociclib (including abemaciclib)
Participants with a history of allergic reactions attributed to compounds of similar chemical or biologic composition to palbociclib, everolimus or exemestane
History of allergic reactions attributed to compounds of similar chemical or biologic composition to ramucirumab
History of allergic reactions attributed to compounds of similar chemical or biologic composition to selumetinib
History of allergic reactions attributed to compounds of similar chemical or biologic composition to bevacizumab
History of allergic reactions attributed to compounds of similar chemical or biologic composition to PLX or sirolimus
A history of allergic reactions attributed to compounds of similar chemical or biologic composition to docetaxel or carboplatin
History of allergic reactions attributed to compounds of similar chemical or biologic composition to nab-P.
History of allergic reactions attributed to compounds of similar chemical or biologic composition to ponatinib
History of clinically significant allergic reactions attributed to compounds of similar chemical or biologic composition to AT or paclitaxel
History of allergic reactions attributed to compounds of similar chemical or biologic composition to everolimus
Patients must not have a history of allergic reactions attributed to compounds of similar chemical or biologic composition to brentuximab vedotin and/or rituximab
History of allergic reactions or adverse reactions (e.g., wound dehiscence) attributed to compounds of similar chemical or biologic composition to PLG or known hypersensitivity to GM-CSF, CPG or PLG
History of allergic reactions attributed to compounds of similar chemical or biologic composition to prexasertib or LY.
History of allergic reactions attributed to compounds of similar chemical or biologic composition to MCS, dabrafenib, or trametinib
History of allergic reactions attributed to compounds of similar chemical or biologic composition to ipilimumab or nivolumab
History of allergic reactions attributed to compounds of similar chemical or biologic composition to BVD-
History of allergic reactions attributed to compounds, or any of its excipients, of similar chemical or biologic composition to osimertinib or selumetinib
History of allergic reactions attributed to compounds of similar chemical or biologic composition to pembrolizumab
History of allergic reactions attributed to compounds of similar chemical or biologic composition to abemaciclib
History of allergic reactions attributed to compounds of similar chemical or biologic composition to daratumumab
Patients must not have a history of allergic reactions attributed to compounds of similar chemical or biologic composition to pembrolizumab
Women with a history of allergic reactions attributed to compounds of similar chemical or biologic composition to Tamoxifen.
History of allergic reactions attributed to compounds of similar chemical or biologic composition to cyclophosphamide (only for arm B)
History of allergic reactions attributed to compounds of similar chemical composition to SY-
History of allergic reactions attributed to compounds of similar chemical or biologic composition to gefitinib or osimertinib
History of allergic reactions attributed to compounds of similar chemical or biologic composition to LY, vemurafenib, or cobimetinib
History of allergic reactions attributed to compounds of similar chemical or biologic composition to apalutamide or docetaxel
History of allergic reactions attributed to compounds of similar chemical or biologic composition to prexasertib or olaparib
History of allergic reactions attributed to compounds of similar chemical or biologic composition to pembrolizumab
History of allergic reactions attributed to compounds of similar chemical or biologic composition to cabozantinib (XL)
History of allergic reactions attributed to compounds of similar chemical or biologic composition to M (VX-) or gemcitabine
History of allergic reactions attributed to compounds of similar chemical or biologic composition to AT (onalespib)
History of allergic reactions attributed to compounds of similar chemical or biologic composition to vemurafenib
History of allergic reactions attributed to compounds of similar chemical or biologic composition to gemcitabine or IMGN
History of allergic reactions attributed to compounds of similar chemical or biologic composition to ibrutinib or venetoclax
Patients with a history of allergic reactions attributed to compounds of similar chemical or biologic composition to HMAs
History of allergic reactions attributed to compounds of similar chemical or biologic composition to merestinib
Participant has a history of allergic reactions attributed to compounds of similar chemical or biologic composition to ACTOplus Met XR
History of allergic reactions attributed to compounds of similar chemical or biologic composition to ixazomib or lenalidomide
Participant with a history of allergic reactions attributed to compounds of similar chemical or biologic composition of retinoids
History of allergic reactions attributed to compounds of similar chemical or biologic composition to prexasertib.
Patients who have a history of allergic reactions attributed to compounds of similar chemical or biologic composition to bevacizumab are not eligible
Subject has a history of allergic reactions attributed to compounds of similar chemical or biologic composition to PROSTVAC or ipilimumab
History of allergic reactions attributed to compounds of similar chemical or biologic composition to sertraline
History of allergic reactions attributed to compounds of similar chemical or biologic composition to sunitinib or everolimus
History of allergic reactions attributed to compounds of similar chemical or biologic composition to temozolomide
History of allergic reactions attributed to compounds of similar chemical or biologic composition to TRC or TMZ
History of allergic reactions attributed to compounds of similar chemical or biologic composition to gemcitabine or docetaxel
History of severe allergic reactions attributed to compounds of similar chemical or biologic composition to bevacizumab, anetumab ravtansine or paclitaxel
History of allergic reactions attributed to compounds of similar chemical or biologic composition to MTX or gadolinium.
History of allergic reactions or hypersensitivity attributed to compounds of similar chemical or biologic composition to olaparib or its excipients
History of allergic reactions attributed to compounds of similar chemical or biologic composition to any in the regimen
Hypersensitivity to chemotherapy or history of allergic reactions attributed to compounds of similar chemical or biologic composition to rituximab, ibrutinib, ICE, Ave, or Uto
History of allergic reactions attributed to compounds of similar chemical or biologic composition to ONC or its excipients.
History of allergic reactions attributed to compounds of similar chemical or biologic composition to apatinib or pembrolizumab
A history of allergic reactions attributed to compounds of similar chemical or biologic composition to palbociclib, cisplatin (for cohort ), or cetuximab (for cohort )
History of allergic reactions attributed to compounds of similar chemical or biologic composition to any of the agents on this trial
History of allergic reactions attributed to compounds of similar chemical or biologic composition to cediranib or olaparib
History of allergic reactions attributed to compounds of similar chemical or biologic composition to MLN (TAK-)
History of allergic reactions attributed to compounds of similar chemical or biologic composition to the study agent or accompanying supportive medications.
The patient has a history of allergic reactions attributed to compounds of chemical or biologic composition similar to those of cetuximab and/or nivolumab
History of allergic reactions attributed to compounds of similar chemical or biologic composition to poxviral vaccines (e.g., vaccinia vaccine)
History of allergic reactions attributed to compounds of similar chemical or biologic composition to ONC or its excipients
History of allergic reactions attributed to compounds of similar chemical or biologic composition to EGF or gefitinib
Subjects with a history of allergic reactions attributed to compounds of similar chemical or biologic composition to IACS-.
History of allergic reactions attributed to compounds of similar chemical or biologic composition to nivolumab
History of allergic reactions attributed to compounds of similar chemical or biologic composition to pembrolizumab or mifepristone
Patients with a known history of allergic reactions attributed to compounds of similar chemical or biologic composition to cabozantinib
History of allergic reactions attributed to compounds of similar chemical or biologic composition to temozolomide or T-DM
History of allergic reactions attributed to compounds of similar chemical or biologic composition to paclitaxel or carboplatin
History of allergic reactions attributed to compounds of similar chemical or biologic composition to topotecan, other topoisomerase inhibitors or gadolinium compounds
Patients with a history of allergic reactions attributed to compounds of similar chemical or biologic composition to HMAs
History of allergic reactions attributed to compounds of similar chemical or biologic composition to lamivudine
History of allergic reactions attributed to compounds of similar chemical or biologic composition to zydelig
History of allergic reactions attributed to compounds of similar chemical or biological composition to cetuximab (anti-EGFR).
History of allergic reactions attributed to compounds of similar chemical or biologic composition to anetumab ravtansine or MK- (pembrolizumab)
Patients who have a history of allergic reactions attributed to compounds of similar chemical or biologic composition to temozolomide are not eligible
History of allergic reactions attributed to compounds of similar chemical or biologic composition to mistletoe
History of allergic reactions attributed to compounds of similar chemical or biologic composition to clarithromycin or taxanes
History of allergic reactions attributed to compounds of similar chemical or biologic composition to CDX- (varlilumab) and/or nivolumab
History of allergic reactions attributed to compounds of similar chemical or biologic composition to HCQ
History of allergic reactions attributed to compounds of chemical or biologic composition similar to palbociclib
History of allergic reactions attributed to compounds of similar chemical or biologic composition to cabozantinib or nivolumab
History of allergic reactions attributed to compounds of similar chemical or biologic composition to olaparib or abiraterone
History of allergic reactions attributed to compounds of similar chemical or biologic composition to TRC or pemetrexed and cisplatin
History of allergic reactions attributed to compounds of similar chemical or biologic composition to cediranib or olaparib
History of allergic reactions attributed to compounds of similar chemical or biologic composition to hydroxychloroquine or received HCQ in the past six months
History of allergic reactions attributed to compounds of similar chemical or biologic composition to fosbretabulin
History of allergic reactions attributed to compounds of similar chemical or biologic composition to pevonedistat or decitabine
History of allergic reactions attributed to compounds of similar chemical or biologic composition to IL-
History of allergic reactions attributed to compounds of similar chemical or biologic composition to cisplatin
History of allergic reactions attributed to compounds of similar chemical or biologic composition to TVB-
History of allergic reactions attributed to compounds of similar chemical or biologic composition to temozolomide and/or TG
History of allergic reactions attributed to compounds of similar chemical or biologic composition to enzalutamide or indomethacin
History of allergic reactions attributed to compounds of similar chemical or biologic composition to pembrolizumab, cisplatin, carboplatin, or etoposide
History of allergic reactions attributed to compounds of similar chemical or biologic composition to ruxolitinib
History of allergic reactions attributed to compounds of similar chemical or biologic composition to daunorubicin
History of allergic reactions attributed to compounds of similar chemical or biologic composition to palbociclib, carboplatin or cisplatin
History of allergic reactions attributed to compounds of similar chemical or biologic composition to durvalumab
History of allergic reactions attributed to compounds of similar chemical or biologic composition to decitabine or talazoparib
History of allergic reactions attributed to compounds of similar chemical or biologic composition to nivolumab including any history of severe allergic reactions to monoclonal antibody therapy
History of allergic reactions attributed to compounds of similar chemical or biologic composition to cisplatin and pemetrexed
History of allergic reactions attributed to compounds of similar chemical or biologic composition to selinexor
History of allergic reactions attributed to compounds of similar chemical or biologic composition to blinatumomab
Patients who have a history of allergic reactions attributed to compounds of similar chemical or biologic composition to pembrolizumab are not eligible AND/OR patients who have had prior exposure to compounds of similar chemical or biologic composition to pembrolizumab are not eligible
Patients who have a history of allergic reactions attributed to compounds of similar chemical or biologic composition to BCG are not eligible
History of allergic reactions attributed to compounds of similar chemical or biologic composition to abiraterone or PDMX/niclosamide
Patients who have a history of allergic reactions attributed to compounds of similar chemical or biologic composition to MEDI are not eligible
History of severe allergic reactions attributed to compounds of similar chemical or biologic composition to lenvatinib and/or paclitaxel
Known hypersensitivity or history of allergic reactions attributed to compounds of similar chemical or biologic composition to IRX
History of allergic reactions attributed to compounds of similar chemical or biologic composition to ibrutinib and brentuximab vedotin (BV)
History of allergic reactions attributed to compounds of similar chemical or biologic composition to ramucirumab or nab-paclitaxel
History of allergic reactions attributed to compounds of similar chemical or biologic composition to dasatinib
A history of allergic reactions attributed to compounds of similar chemical or biologic composition to erlotinib, temozolomide, or dacarbazine
History of allergic reactions attributed to compounds of similar chemical or biologic composition to capecitabine or bevacizumab
History of allergic reactions attributed to compounds of similar chemical or biologic composition to poxviral vaccines (e.g., vaccinia vaccine)
History of allergic reactions attributed to compounds of similar chemical or biologic composition to nab-paclitaxel
History of allergic reactions attributed to compounds of similar chemical or biologic composition to ruxolitinib or bortezomib
History of allergic reactions attributed to compounds of similar chemical or biologic composition to nivolumab
History of allergic reactions attributed to compounds of similar chemical or biologic composition to pembrolizumab, paclitaxel or carboplatin
Subjects with a known history of allergic reactions attributed to compounds of similar chemical or biologic composition to DSb
History of allergic reactions attributed to compounds of similar chemical or biologic composition to methoxyamine or to pemetrexed or cisplatin
History of allergic reactions attributed to compounds of similar chemical or biologic composition to cabozantinib
History of allergic reactions attributed to compounds of similar chemical or biologic composition to study drugs
History of allergic reactions attributed to compounds of similar chemical or biologic composition to MEDI- or history of anaphylaxis to any biological component
History of allergic reactions attributed to compounds of similar chemical or biologic composition to leflunomide or cholestyramine
History of allergic reactions attributed to compounds of similar chemical or biologic composition to talimogene laherparepvec
History of allergic reactions attributed to compounds of similar chemical or biologic composition to any in the pre- or post-transplant regimen
History of allergic reactions attributed to compounds of similar chemical or biologic composition to cediranib or olaparib
History of allergic reactions attributed to compounds of similar chemical or biologic composition to pemetrexed
Patients with history of allergic reactions attributed to compounds of similar chemical; or biologic composition to vorinostat or temsirolimus are not eligible
History of allergic reactions attributed to compounds of similar chemical or biologic composition to IPdR
Prior allergic reactions attributed to compounds of similar chemical or biologic composition to dabrafenib or trametinib
History of allergic reactions attributed to compounds of similar chemical or biologic composition to temozolomide
History of allergic reactions attributed to compounds of similar chemical or biologic composition to basiliximab
History of allergic reactions attributed to compounds of similar chemical or biologic composition to enzalutamide or metformin
History of allergic reactions attributed to compounds of similar chemical or biologic composition to GDC-
History of allergic reactions attributed to compounds of similar chemical or biologic composition to VOR or HCQ
History of allergic reactions attributed to compounds of similar chemical or biologic composition to ponatinib
History of allergic reactions attributed to compounds of similar chemical or biologic composition to ONC or its excipients
History of allergic reactions attributed to compounds of similar chemical or biologic composition to MLN (TAK-) or ziv-aflibercept
A history of allergic reactions attributed to compounds of similar chemical or biologic composition to docetaxel or carboplatin
History of allergic reactions attributed to compounds of similar chemical or biologic composition to etoposide
History of allergic reactions attributed to compounds of similar biologic composition to M or to IL-
History of allergic reactions attributed to compounds of similar chemical or biologic composition to propranolol
History of prior allergic reactions attributed to compounds of similar chemical or biologic composition as capecitabine
History of allergic reactions attributed to compounds of similar chemical or biologic composition to melphalan
History of allergic reactions attributed to compounds of similar chemical or biologic composition to DOPC, Magnevist, or fluorodeoxyglucose (FDG)
History of allergic reactions attributed to compounds of similar chemical or biologic composition to cisplatin for patients who will receive chemotherapy
History of allergic reactions attributed to compounds of similar chemical or biologic composition to IPdR
History of allergic reactions attributed to compounds of similar chemical or biologic composition to metformin
EXCLUSION CRITERIA FOR REGISTRATION: history of allergic reactions attributed to compounds of similar chemical or biologic composition to metformin
History of allergic reactions attributed to compounds of similar chemical or biological composition to Valproic Acid
History of allergic reactions attributed to compounds of similar chemical or biologic composition to TCN-PM
History of allergic reactions to compounds of similar chemical or biologic composition to talactoferrin or the chemotherapy drugs
History of allergic reactions attributed to compounds of similar chemical composition to IHL-
History of allergic reactions attributed to compounds of similar chemical or biologic composition to cenersen.
History of allergic reactions attributed to compounds of similar chemical or biologic composition to copanlisib and/or nivolumab
History of allergic reactions attributed to compounds of similar chemical or biologic composition to CPI- or docetaxel
History of allergic reactions attributed to compounds of similar chemical or biologic composition to tamoxifen
History of allergic reactions attributed to compounds of similar chemical or biologic composition to -fluorouracil or imiquimod
History of allergic reactions attributed to compounds of similar chemical or biologic composition to CPI-
History of allergic reactions attributed to compounds of similar chemical or biologic composition;
History of allergic reactions attributed to compounds of similar chemical or biologic composition to study drugs
History of allergic reactions attributed to compounds of similar chemical or biologic composition to study drugs; patients who have previously received either clofarabine or bortezomib will be excluded
History of allergic reactions attributed to compounds of similar chemical or biologic composition to lenvatinib
History of allergic reactions attributed to compounds of similar chemical or biologic composition to durvalumab or any excipient or any egg products
History of allergic reactions attributed to compounds of similar chemical or biologic composition to enzalutamide or PDMX/niclosamide
Participants who have a history of allergic reactions attributed to compounds of similar chemical or biologic composition to birinapant or its constituents
History of allergic reactions attributed to compounds of similar chemical or biologic composition to WP
History of allergic reactions attributed to compounds of similar chemical or biologic composition to M (VX), cisplatin, or gemcitabine
History of allergic reactions attributed to compounds of similar chemical or biologic composition to navitoclax or sorafenib
Patients with a history of hypersensitivity or allergic reactions attributed to compounds of similar chemical or biologic composition to AMG  are ineligible
History of allergic reactions attributed to compounds of similar chemical or biologic composition to nelfinavir
History of allergic reactions attributed to compounds of similar chemical or biologic composition to abemaciclib
History of allergic reactions attributed to compounds of similar chemical or biologic composition to measles virus vaccination
History of allergic reactions attributed to compounds of similar chemical or biologic composition to XL
Subjects with history of allergic reactions attributed to compounds of similar chemical or biologic composition to AMG  or carfilzomib, lenalidomide, or dexamethasone
Patients with a history of allergic reactions attributed to compounds of similar chemical or biologic composition to BAL are ineligible
History of allergic reactions attributed to compounds of similar chemical or biologic composition to quinacrine, capecitabine or fluorouracil
History of allergic reactions attributed to compounds of similar chemical or biologic composition to navitoclax or vistusertib
History of allergic reactions attributed to compounds of similar chemical or biologic composition to nivolumab
History of allergic reactions attributed to compounds of similar chemical or biologic composition to tazemetostat
History of allergic reactions attributed to compounds of similar chemical or biologic composition to TAS- or TMZ
History of allergic reactions attributed to compounds of similar chemical or biologic composition to olaparib, cediranib, carboplatin, cisplatin, or etoposide
History of allergic reactions attributed to compounds of similar chemical or biologic composition to veliparib and MM-; if patients have a history of allergic reactions to compounds resembling MM-, they will be excluded from participating in the FMX MRI study, if applicable
History of allergic reactions attributed to compounds of similar chemical or biologic composition to VX-, carboplatin, gemcitabine or to these specific compounds
History of allergic reactions attributed to compounds of similar chemical or biologic composition to triapine or cisplatin
History of allergic reactions attributed to compounds of similar chemical or biologic composition to nivolumab
History of allergic reactions attributed to compounds of similar chemical or biologic composition to MK- and ziv-aflibercept
History of allergic reactions attributed to compounds of similar chemical or biologic composition to briciclib
History of allergic reactions attributed to compounds of similar chemical or biologic composition to ruxolitinib
History of allergic reactions attributed to compounds of similar chemical or biologic composition to study drugs (e.g. cisplatin, paclitaxel)
History of allergic reactions attributed to compounds of similar chemical or biologic composition to carfilzomib or belinostat
History of allergic reactions to compounds with similar biologic or chemical composition to pembrolizumab or radium-
History of allergic reactions attributed to compounds of similar chemical or biologic composition to CYT
History of allergic reactions or hypersensitivity attributed to compounds of similar chemical or biologic composition to metformin, ritonavir or any of their ingredients
Have history of allergic reactions attributed to compounds of similar chemical or biologic composition to taxanes (docetaxel or paclitaxel) or cyclophosphamide
History of allergic reactions attributed to compounds of similar chemical or biologic composition to nivolumab
History of allergic reactions attributed to compounds of similar chemical or biologic composition to Dex or Enza
History of allergic reactions attributed to compounds of similar chemical or biologic composition to either -FU/capecitabine or interferon
History of allergic reactions attributed to compounds of similar chemical or biologic composition to TPI 
History of allergic reactions attributed to compounds of similar chemical or biologic composition to MLN or bevacizumab
History of allergic reactions attributed to compounds of similar chemical or biologic composition to gemcitabine, nab-paclitaxel or enzalutamide
History of allergic reactions attributed to compounds of similar chemical or biologic composition to INCB, MELITAC ., or other vaccine components
History of allergic reactions attributed to compounds of similar chemical or biologic composition to cetuximab or ipilimumab
Patients with a history of allergic reactions attributed to compounds of similar chemical or biologic composition to sorafenib, bortezomib or decitabine that are not easily managed
History of allergic reactions attributed to compounds of similar chemical or biologic composition to PF-
No history of allergic reactions attributed to compounds of similar chemical or biologic composition to cabozantinib, temozolomide and dacarbazine
History of allergic reactions attributed to compounds of similar chemical or biologic composition to vorinostat
History of allergic reactions attributed to compounds of similar chemical or biologic composition to digoxin
History of allergic reactions attributed to compounds of similar chemical or biologic composition to dasatinib, erlotinib or gemcitabine
History of allergic reactions attributed to compounds of similar chemical or biologic composition of decitabine, cytarabine or daunorubicin
History of allergic reactions attributed to compounds of similar chemical or biologic composition to lenalidomide (i.e. thalidomide)
Patients must not have a history of allergic reactions attributed to compounds of similar chemical or biologic composition to afatinib and/or cetuximab
History of allergic reactions attributed to compounds of similar chemical composition to afatinib
History of allergic reactions attributed to compounds of similar chemical or biologic composition to pazopanib
Patient must have no history of allergic reactions attributed to compounds of similar chemical or biologic composition to pazopanib
History of allergic reactions attributed to compounds of similar chemical or biologic composition to MK- (pembrolizumab)
History of allergic reactions attributed to compounds of similar chemical or biologic composition to VX-
History of allergic reactions attributed to compounds of similar chemical or biologic composition to M (VX-) or cisplatin
History of Grade  or  allergic reactions attributed to compounds of similar chemical or biologic composition as MSCA
History of allergic reactions attributed to compounds of similar chemical or biologic composition to ibrutinib
History of allergic reactions attributed to compounds of similar chemical or biologic composition to metformin or rapamycin
History of allergic reactions attributed to compounds of similar chemical or biologic composition to mitomycin-C or -fluorouracil
History of allergic reactions attributed to compounds of similar chemical or biologic composition to vorinostat or HCQ
History of allergic reactions attributed to compounds of similar chemical or biologic composition to daunorubicin or cytarabine
History of allergic reactions attributed to compounds or similar chemical or biological composition to ibrutinib
History of allergic reactions attributed to compounds of similar chemical or biologic composition to mocetinostat or brentuximab vedotin
Patients with history of allergic reactions attributed to compounds of similar chemical or biologic composition to decitabine that are not easily managed
History of allergic reactions attributed to compounds of similar chemical or biologic composition to hydroxychloroquine
History of allergic reactions attributed to compounds of similar chemical or biologic composition to dacomitinib
History of allergic reactions attributed to compounds of similar chemical or biologic composition to dasatinib or any of the components of the vaccine being administered as part of this study
History of allergic reactions attributed to compounds of similar chemical or biologic composition to MLN, bortezomib or rituximab
History of allergic reactions attributed to compounds of similar chemical or biologic composition to AMG  or decitabine
Patients who have a history of allergic reactions or hypersensitivity reactions attributed to compounds of similar chemical or biologic composition to pembrolizumab and/or humanized antibodies are not eligible
History of allergic reactions attributed to compounds of similar chemical or biologic composition to bevacizumab or atezolizumab
History of severe allergic reactions attributed to compounds of similar chemical or biologic composition to nivolumab or lenalidomide
Patients with a history of allergic reactions attributed to bevacizumab or to compounds of similar chemical or biologic composition to nivolumab or bevacizumab are excluded
Patients who have a history of allergic reactions attributed to compounds of similar chemical or biologic composition to nivolumab are not eligible
History of allergic reactions attributed to compounds of similar chemical or biologic composition to poxviral vaccines (e.g., vaccinia vaccine)
History of allergic reactions attributed to compounds of similar chemical or biologic composition to MGE
History of allergic reactions attributed to compounds of similar chemical or biologic composition to palbociclib and/or bazedoxifene
History of allergic reactions attributed to compounds of similar chemical or biologic composition to PM or trabectedin (Yondelis, ET-)
History of allergic reactions attributed to compounds of similar chemical or biologic composition to ONC or its excipients
Participants may not have a history of allergic reactions attributed to compounds of similar chemical or biologic composition to cediranib or olaparib
History of allergic reactions attributed to compounds of similar chemical or biologic composition to nivolumab
Patient has a history of allergic reactions attributed to compounds of similar chemical or biologic composition to PBI- (i.e., cardiac glycoside compounds).
History of severe allergic reactions attributed to compounds of similar chemical or biologic composition to IL-
History of allergic reactions attributed to compounds of similar chemical or biologic composition to nivolumab
History of allergic reactions attributed to compounds of similar chemical or biologic composition to elotuzumab or lenalidomide
Patient has a history of allergic reactions attributed to compounds of similar chemical or biologic composition to MK-
Prior treatment with or allergic reactions attributed to compounds of similar chemical or biologic composition to ponatinib
Patients must not have a known history of allergic reactions attributed to compounds of similar chemical or biologic composition to perifosine or temsirolimus
Patients must not have a history of allergic reactions attributed to compounds of similar chemical or biologic composition to temsirolimus or perifosine
History of allergic reactions attributed to compounds of similar chemical or biologic composition to crizotinib or enzalutamide
History of allergic reactions attributed to compounds of similar chemical or biologic composition to gemcitabine and eribulin
History of allergic reactions attributed to compounds of similar chemical or biologic composition to X-, docetaxel, or granulocyte colony stimulating factors
History of severe allergic reactions attributed to compounds of similar chemical or biologic composition to ofatumumab or idelalisib
History of allergic reactions attributed to compounds of similar chemical or biologic composition to carboplatin or docetaxel
Patients with history of allergic reactions attributed to compounds of similar chemical or biologic composition to decitabine that are not easily managed
Research participants with a history of allergic reactions attributed to compounds of similar chemical or biological composition to cetuximab
PHASE I: History of allergic reactions attributed to compounds of similar chemical or biologic composition to ruxolitinib
PHASE II: History of allergic reactions attributed to compounds of similar chemical or biologic composition to ruxolitinib
History of allergic reactions attributed to compounds of similar chemical or biologic composition to palbociclib
History of allergic reactions attributed to compounds of similar chemical or biologic composition to cabozantinib
History of allergic reactions attributed to compounds of similar chemical or biologic composition to entinostat, azacitidine, or nivolumab
History of allergic reactions attributed to compounds of similar chemical or biologic composition to rucaparib.
Participants who have a history of allergic reactions attributed to compounds of similar chemical or biologic composition to neratinib or fulvestrant
History of allergic reactions attributed to lenalidomide or compounds of similar chemical or biologic composition to lenalidomide including thalidomide
PART B: History of allergic or severe reactions attributed to compounds of similar chemical or biologic composition to ponatinib
History of grade  or  allergic reactions attributed to compounds of similar chemical or biologic composition to ARRY- or trastuzumab
History of allergic reactions attributed to compounds of similar chemical or biologic composition to ibrutinib or lenalidomide
History of allergic reactions attributed to compounds of similar chemical or biologic composition to tivozanib or enzalutamide
History of allergic reactions attributed to compounds of similar chemical or biologic composition to enzalutamide or poxviral vaccines (e.g., vaccinia vaccine)
History of allergic reactions attributed to compounds of similar chemical or biologic composition to enzalutamide or poxviral vaccines (e.g., vaccinia vaccine)
History of allergic reactions attributed to compounds of similar chemical or biologic composition to AUY
History of allergic reactions attributed to compounds of similar chemical or biologic composition to midostaurin and/or decitabine
History of allergic reactions attributed to compounds of similar chemical or biologic composition to sunitinib
History of allergic reactions attributed to compounds of similar chemical or biologic composition to capecitabine
Patients must NOT have history of allergic reactions attributed to compounds of similar chemical or biologic composition to temozolomide or capecitabine
History of allergic reactions attributed to, or intolerance of, or other significant toxicity with, compounds of similar chemical or biologic composition to X- or everolimus
REGISTRATION EXCLUSION CRITERIA: History of allergic reactions attributed to compounds of similar chemical or biologic composition to trastuzumab
History of allergic reactions attributed to compounds of similar chemical or biologic composition to bevacizumab
History of allergic reactions attributed to compounds of similar chemical or biological composition as ARQ 
History of allergic reactions attributed to compounds of similar chemical or biologic composition to temozolomide
History of allergic reactions attributed to compounds of similar chemical or biologic composition to lenalidomide (including thalidomide), clarithromycin, or melphalan
History of allergic reactions attributed to compounds of similar chemical or biologic composition to FLT
History of allergic reactions attributed to compounds of similar chemical or biologic composition to dexanabinol
History of allergic reactions attributed to compounds of similar chemical or biologic composition to black cohosh
History of allergic reactions attributed to compounds of similar chemical or biologic composition to sunitinib
History of allergic reactions attributed to compounds of similar chemical or biologic composition to vorinostat
History of allergic reactions attributed to compounds of similar chemical or biologic composition to sorafenib
History of allergic reactions attributed to compounds of similar chemical or biologic composition to ABT- or abiraterone
History of allergic reactions attributed to compounds of similar chemical or biologic composition to fulvestrant or ganetespib
History of allergic reactions attributed to compounds of similar chemical or biologic composition to neratinib (or to capecitabine for cohorts a/b)
History of allergic reactions attributed to compounds of similar chemical or biologic composition to capecitabine and hydroxychloroquine (HCQ)
History of allergic reactions attributed to compounds of similar chemical or biologic composition to plerixafor or bevacizumab
History of allergic reactions attributed to compounds of similar chemical or biologic composition to AMG 
History of allergic reactions to palbociclib or attributed to compounds of similar chemical or biologic composition to palbociclib
History of allergic reactions attributed to compounds of similar chemical or biologic composition to cediranib maleate or olaparib
History of allergic reactions attributed to compounds of similar chemical or biologic composition to PF-
History of allergic reactions attributed to compounds of similar chemical or biologic composition to BMN (talazoparib)
History of allergic reactions attributed to compounds of similar chemical or biologic composition to ibrutinib or idarubicin or cytarabine
Patients with a history of allergic reactions attributed to compounds of similar chemical or biologic composition to platinums, taxanes or fluoropyrimidines
Prior allergic reactions attributed to compounds of similar chemical or biologic composition to gemcitabine (gemcitabine hydrochloride) or cisplatin
History of allergic reactions attributed to compounds of similar chemical or biologic composition to MK- or cisplatin
History of allergic reactions attributed to compounds of similar chemical or biologic composition to erlotinib or clindamycin (topical agent for potential skin toxicity)
History of allergic reactions attributed to compounds of similar chemical or biologic composition to erlotinib
History of allergic reactions attributed to compounds of similar chemical or biologic composition to ibrutinib
History of allergic reactions attributed to compounds of similar chemical or biologic composition to ibrutinib
History of allergic reactions attributed to compounds of similar chemical or biologic composition to MEK, anthracycline, or cytarabine
History of allergic reactions attributed to compounds of similar chemical or biologic composition to lapatinib
History of allergic reactions attributed to compounds of similar chemical or biologic composition to peg-IFN?-b
History of allergic reactions attributed to compounds of similar chemical or biologic composition to SS(dsFv)PE
History of allergic reactions attributed to compounds of similar chemical or biologic composition to MPDLA, carboplatin, or paclitaxel
Patient with history of allergic reactions or hypersensitivity attributed to compounds of similar chemical or biologic composition to enzalutamide, carboplatin, or paclitaxel
History of allergic reactions attributed to compounds of similar chemical or biologic composition to palbociclib
History of allergic reactions attributed to compounds of similar chemical or biologic composition to erlotinib and/or onalespib
History of allergic reactions attributed to compounds of similar chemical or biologic composition to onalespib or ATM
History of allergic reactions attributed to compounds of similar chemical or biologic composition to MLN (TAK-)
History of allergic reactions attributed to compounds of similar chemical or biologic composition to vorinostat or temsirolimus
Patients with history of allergic reactions attributed to compounds of similar chemical or biologic composition to belinostat, including hydroxamate compounds or arginine
History of allergic reactions attributed to compounds of similar chemical or biologic composition to lithium carbonate
History of allergic reactions attributed to compounds of similar chemical or biologic composition to dinaciclib or to MK-
History of allergic reactions attributed to compounds of similar chemical or biologic composition to carboplatin, or nab-paclitaxel
History of allergic reactions attributed to compounds of similar chemical or biologic composition to gemcitabine (gemcitabine hydrochloride) or cisplatin
History of allergic reactions attributed to compounds of similar chemical or biologic composition to MK-
History of allergic reactions attributed to compounds of similar chemical or biologic composition to ibrutinib or R-ICE
History of allergic reactions attributed to compounds of similar chemical or biologic composition to tivozanib
History of allergic reactions attributed to compounds of similar chemical or biologic composition to MK-
Known hypersensitivity/history of allergic reactions attributed to compounds of similar chemical or biologic composition to everolimus or fulvestrant.
Known hypersensitivity to ipilimumab or history of allergic reactions attributed to compounds of similar chemical or biologic composition to ipilimumab
History of allergic reactions attributed to compounds of similar chemical or biologic composition to Cabazitaxel, or to drugs formulated with polysorbate .
History of allergic reactions attributed to compounds of similar chemical or biologic composition to rituximab
History of allergic reactions attributed to compounds of similar chemical or biologic composition as TG citrate.
History of allergic reactions attributed to compounds of similar chemical or biologic composition to pioglitazone
History of allergic reactions attributed to compounds of similar chemical or biologic composition to dasatinib and ipilimumab
History of allergic reactions attributed to compounds of similar chemical or biologic composition to dabrafenib and its excipients.
History of allergic reactions attributed to compounds of similar chemical or biologic composition to panitumumab
History of allergic reactions attributed to compounds of similar chemical or biologic composition to ARQ  or temsirolimus
History of allergic reactions attributed to compounds of similar chemical or biologic composition to vemurafenib or leflunomide
History of allergic reactions attributed to compounds of similar chemical or biologic composition to erlotinib
History of allergic reactions attributed to compounds of similar chemical or biologic composition to MLN, including but not limited to established allergic reaction to benzodiazepines
History of allergic reactions attributed to compounds of similar chemical or biologic composition to RAD or SOM (pasireotide)
History of allergic reactions attributed to compounds of similar chemical or biologic composition to sorafenib or hydroxychloroquine
The participant has a history of allergic reactions attributed to compounds of chemical or biologic composition similar to that of cixutumumab or to octreotide
History of allergic reactions attributed to compounds of similar chemical or biologic composition to talimogene laherparepvec
Patients who have a history of allergic reactions attributed to compounds of similar chemical or biologic composition to volasertib or VSLI are not eligible
History of allergic reactions attributed to compounds of similar chemical or biologic composition to talazoparib
History of allergic reactions attributed to compounds of similar chemical or biologic composition to bevacizumab, nab-paclitaxel or temozolomide
Patients must not have a known history of allergic reactions attributed to compounds of similar chemical or biologic composition
History of allergic reactions attributed to compounds of similar chemical or biologic composition to eribulin mesylate or pembrolizumab
History of allergic reactions attributed to tamoxifen or compounds of similar chemical or biologic composition
History of allergic reactions attributed to compounds of similar chemical or biologic composition to CUDC-
History of allergic reactions attributed to compounds of similar chemical or biologic composition to apalutamide, abiraterone acetate, or other study drugs
History of severe (i.e. anaphylactic) allergic reactions attributed to compounds of similar chemical or biologic composition to glucocorticoids and other component of R-
History of allergic reactions attributed to compounds of similar chemical or biologic composition to cadaveric component, i.e. Flex HD
History of allergic reactions attributed to compounds of similar chemical or biologic composition to Adriamycin, dacarbazine, or brentuximab
History of allergic reactions attributed to compounds of similar chemical or biologic composition to naltrexone
No investigational agent, so no exclusion requirements regarding history of allergic reactions attributed to compounds of similar chemical or biologic composition to investigational agent or device
Patient must not have a history of allergic reactions attributed to compounds of similar chemical or biologic composition to lithium carbonate
History of allergic reactions attributed to compounds of similar chemical or biologic composition to ruxolitinib
History of allergic reactions attributed to compounds of similar chemical or biologic composition to erlotinib
History of allergic reactions to yeast or attributed to compounds of similar chemical or biologic composition to Gardasil  HPV vaccine
History of allergic reactions attributed to compounds of similar chemical or biologic composition to exemestane
History of allergic reactions attributed to compounds of similar chemical or biologic composition to erlotinib (Tarceva)
History of allergic reactions attributed to compounds of similar chemical or biologic composition to -OHT gel
History of adverse effects, intolerance, or allergic reactions attributed to compounds of similar chemical or biologic composition to simvastatin (i.e., other statin medications)
History of allergic reactions attributed to compounds of similar chemical or biologic composition to NeuVax
History of allergic reaction to zileuton or attributed to compounds of similar chemical or biologic composition to zileuton
History of allergic reactions attributed to compounds of similar chemical or biologic composition to MUC/Poly?ICLC
History of adverse effects, intolerance, or allergic reactions attributed to compounds of similar chemical or biologic composition to simvastatin (i.e., other statin medications)
History of allergic reactions attributed to compounds of similar chemical or biologic composition to WOKVAC
History of allergic reactions attributed to compounds of similar chemical or biologic composition to Avmacol
History of allergic reactions attributed to compounds of similar chemical or biologic composition to bexarotene gel, oral or topical retinoids
History of allergic reactions or intolerance attributed to aspirin or compounds of similar chemical or biologic composition
History of allergic reactions attributed to compounds of similar chemical or biologic composition to green tea or EGCG
History of allergic reactions attributed to compounds of similar chemical or biologic composition to Meriva
Patients with a history of allergic reactions attributed to compounds of similar chemical or biologic composition of alendronate and other bisphosphonates
Documented history of allergic reactions attributed to compounds of similar chemical or biologic composition to buproprion
History of allergic reactions attributed to compounds of similar chemical or biologic composition to aspirin
Participants must not have a history of allergic reactions attributed to compounds of similar chemical or biologic composition of iloprost
History of adverse effects, intolerance, or allergic reactions attributed to compounds of similar chemical or biologic composition to pravastatin (i.e., other statin medications)
History of allergic reactions attributed to compounds of similar chemical or biologic composition of PROSTVAC
Participants with a history of allergic reactions attributed to compounds of similar chemical or biologic composition to berberine will be excluded
History of allergic reactions attributed to compounds of similar chemical or biologic composition to telapristone (i.e. other progesterone antagonists)
History of allergic reactions attributed to compounds of similar chemical or biologic composition to PFE
A history of allergic reactions attributed to compounds of similar chemical or biologic composition to tamoxifen
History of allergic reactions attributed to compounds of similar chemical composition to YF
History of allergic reactions attributed to aspirin or compounds of similar chemical or biologic composition to the study agent
History of allergic reactions attributed to compounds of similar chemical or biologic composition to the study agent
Patients with a history of allergic reactions attributed to compounds of similar chemical or biologic composition to MLN (TAK-) are ineligible
History of allergic reactions attributed to compounds of similar chemical or biologic composition to romidepsin, including cyclic tetrapeptide compounds
History of allergic reactions attributed to compounds of similar chemical or biologic composition to linaclotide
Participants with a history of allergic reactions attributed to compounds of similar chemical or biologic composition of retinoids
History of allergic reactions attributed to compounds of similar chemical or biologic composition to PBR
History of allergic reactions attributed to compounds of similar chemical or biologic composition to temozolomide or FMISO
History of allergic reactions attributed to compounds of similar chemical or biologic composition to demeclocycline
SURGICAL ARM: history of allergic reactions attributed to compounds of similar chemical or biologic composition to tetracyclines
History of allergic reactions attributed to compounds of similar chemical or biologic composition to ferumoxytol
History of allergic reactions attributed to compounds of similar chemical or biologic composition to magnetic resonance (MR) contrast material
History of allergic reactions attributed to compounds of similar chemical or biologic composition to FDHT
History of allergic reactions attributed to compounds of similar chemical or biologic composition to L-[methyl-C]methionine
History of allergic reactions attributed to compounds of similar chemical or biologic composition to lorlatinib
History of allergic reactions attributed to compounds of similar chemical or biologic composition to aminolevulinic acid (ALA)
History of allergic reactions attributed to compounds of similar chemical or biologic composition to Eovist
History of allergic reactions attributed to compounds of similar chemical or biologic composition to vitamin D
History of allergic reactions attributed to compounds of similar chemical or biologic composition to idelalisib
The participant has a history of allergic reactions attributed to compounds of chemical or biologic composition similar to those of cetuximab or cisplatin.
The participant has a history of allergic reactions attributed to compounds of chemical or biologic composition similar to those of cetuximab or carboplatin.
History of allergic reactions attributed to compounds of similar chemical or biologic composition to nivolumab, ipilimumab, or blinatumomab
History of allergic reactions attributed to compounds of similar chemical or biologic composition to cetuximab.
